Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Lilly Sues U.S. to Change Hospital Drug Discount Payments
11:18am, Friday, 15'th Nov 2024
The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program
09:40am, Friday, 15'th Nov 2024
Eli Lilly (LLY) became the second drugmaker in recent days to sue the U.S. government for rejecting their proposed changes to a program that requires selling discounted drugs to certain medical facili
Lilly sues US agency over blocking of drug-rebate program
12:06am, Friday, 15'th Nov 2024
Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to hospitals.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
11:19pm, Thursday, 14'th Nov 2024
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 515.88% and currently trading at $814.25. The company has been around since 1876 and the
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
02:25pm, Thursday, 14'th Nov 2024
On Wednesday, Eli Lilly And Co LLY released detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide.
2 Top Growth Stocks to Buy on the Dip
07:00am, Thursday, 14'th Nov 2024
Their recent issues are nothing to fret over for investors focused on the long game.
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
06:19am, Thursday, 14'th Nov 2024
These are income stocks you can buy and hold forever.
SURMOUNT-1 results show a 94% reduction in risk of progression to type 2 diabetes across all pooled doses of tirzepatide compared to placebo over three years Results suggest one new case of diabetes c
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
05:03pm, Wednesday, 13'th Nov 2024
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections.
2 S&P 500 Dividend Stocks That Could Soar 30% or More, According to a Pair of Wall Street Analysts
04:57am, Wednesday, 13'th Nov 2024
If Wall Street's right, investors will get a lot more than just rising dividend payments from this pair.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
09:04pm, Tuesday, 12'th Nov 2024
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 531.19% and currently trading at $834.50. The company has been around since 1876 and the
Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal
05:41pm, Tuesday, 12'th Nov 2024
RISES OVER 1.6% AT IT'S HIGH FOR THE DAY AFTER EARLY DROP AND THE POWER INFLOW SIGNAL
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
04:01pm, Monday, 11'th Nov 2024
One can stay invested in LLY stock as it still has growth prospects despite disappointing sales of Mounjaro and Zepbound in the third quarter.
NVS or LLY: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 11'th Nov 2024
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis (NVS) or Eli Lilly (LLY). But which of these two companies is the best option for those look
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
12:05pm, Sunday, 10'th Nov 2024
Conditions are getting a bit more challenging for the drugmaker.
